BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32202225)

  • 41. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.
    Sivaraman P; Lye WC
    Biomed Pharmacother; 2001 Sep; 55(7):366-8. PubMed ID: 11669498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH; Montone KT; Leahey AM; Hodinka RL; Salhany KE; Belchis DA; Tomaszewski JE
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
    Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
    Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.
    Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A
    Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus infections in children after transplantation of the small intestine.
    Finn L; Reyes J; Bueno J; Yunis E
    Am J Surg Pathol; 1998 Mar; 22(3):299-309. PubMed ID: 9500771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
    Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
    Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.
    Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE
    Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
    Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
    Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
    Caduff N; McHugh D; Murer A; Rämer P; Raykova A; Landtwing V; Rieble L; Keller CW; Prummer M; Hoffmann L; Lam JKP; Chiang AKS; Raulf F; Azzi T; Berger C; Rubic-Schneider T; Traggiai E; Lünemann JD; Kammüller M; Münz C
    PLoS Pathog; 2020 Apr; 16(4):e1008477. PubMed ID: 32251475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
    White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
    J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.
    Covassin L; Jangalwe S; Jouvet N; Laning J; Burzenski L; Shultz LD; Brehm MA
    Clin Exp Immunol; 2013 Dec; 174(3):372-88. PubMed ID: 23869841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
    Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
    Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
    Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
    Koh BY; Rosenthal P; Medeiros LJ; Osorio RW; Roberts JP; Ascher NL; Gelb AB
    Arch Pathol Lab Med; 2001 Mar; 125(3):337-43. PubMed ID: 11231479
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Chandra S; Cristofori P; Fonck C; O'Neill CA
    Toxicol Pathol; 2019 Jul; 47(5):656-660. PubMed ID: 31064282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.